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Abstract
Sox9 is a transcription factor that is required for tissue development in mammals. In general, such transcription factors
require co-regulators for precise temporal and spatial control of the activation and inactivation of the numerous genes
necessary for precise development during embryogenesis. Here we identify a new Sox9 co-regulator: Using affinity
chromatography with immobilized Sox9 protein, we identified exportin 4 (Exp4) as an interacting protein of Sox9 in human
cultured cells. Interaction between endogenous Exp4 and Sox9 proteins was confirmed in the human osteosarcoma U2OS
cells by immunoprecipitation experiments using anti-Sox9 antibody. siRNA depletion of Exp4 enhanced transcription of
Sox9 target genes in U2OS cells, but did not affect nuclear localization of Sox9. These results suggest that Exp4 regulates
Sox9 activity in the nucleus. Furthermore we found that the HMG box of Sox9 was responsible for binding to Exp4, and the
HMG box was required for suppression of Sox9-mediated transcription. This contrasts with the known Sox9 co-regulators
which bind to its transcriptional activation domain. Chromatin immunoprecipitation analyses revealed that Exp4 prevents
Sox9 binding to the enhancers of its target genes. These results demonstrate that Exp4 acts as a Sox9 co-regulator that
directly regulates binding of Sox9 to its target genes.
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Introduction
Sox family genes encode transcription factors and belong to a
superfamily of genes characterized by a homologous sequence
called the high-mobility group (HMG) box. The HMG box is a
DNA-binding domain that is highly conserved between species. A
family of 20 Sox genes is present in humans and mice. The
proteins they encode are divided into 10 subgroups, named
alphabetically from A to J, according to their HMG domain
homology [1].
The Sox HMG domain is known to bind to specific DNA sites,
and to thereby activate transcription of target genes [2]. In
addition, the domain has a role in the subcellular localization of
the Sox proteins [3]. Independent nuclear localization signals
(NLS) have been identified at each end of the HMG domain,
designated the N-terminal NLS and the C-terminal NLS; these
NLS regions may bind different factors. [4,5]. A nuclear export
signal (NES) has also been identified within the HMG domain, in
the region located between the two NLSs [6].
Sox9 is a member of group E and has a role in tissue-specific
development such as chondrogenesis and male gonadal develop-
ment. It has been shown that heterozygous defects in the human
Sox9 gene lead to campomelic dysplasia, a skeletal malformation
syndrome, which is often linked to XY sex reversal syndrome
[7,8]. In chondrogenesis, a minimal DNA element in intron 1 of
the gene is responsible for chondrocyte-specific expression of type
II collagen alpha 1 (Col2a1) which is abundant in the early steps of
chondrocyte differentiation [9]. This element, which has strong
chondrocyte-specific enhancer activity, is a direct target of Sox9
[10].
Several Sox9-interacting proteins have been identified as factors
which regulate the transcriptional activity of Sox9, e.g., TRAP230
protein [11], CREB-binding protein (CBP)/p300 [12], PGC-1a
[13], PIAS proteins [14] and Tip60 [15]. All these proteins
interact with Sox9 through binding to a C terminal region of Sox9,
the transcriptional activation (TA) domain [16,17]. These
interactions contribute to the regulation of Sox9-mediated
transcription at the Sox9-specific target promoter [18,19].
In order to understand the molecular mechanisms of Sox9-
dependent transcriptional activation in more detail, we performed
in vitro pull-down experiments to identify other major interaction
partner proteins of Sox9. We identified Exp4 as a Sox9-binding
protein by mass spectrometry analysis. Exp4 is a member of the
importin b superfamily and is known to export eukaryotic
translation initiation factor 5A (eIF-5A) and Smad3 to the
cytoplasm in a Ran-dependent manner [20,21]. Furthermore,
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25694we found that Exp4 binds to the HMG box of Sox9, unlike the
previously indentified co-regulators, and suppresses transcriptional
activity by inhibiting DNA binding of Sox9. Here we demonstrate
that Exp4 is a modulator of Sox9-mediated transcription.
Results
Identification of proteins that interact specifically with
Sox9
To identify proteins that specifically interact with Sox9, full
length FLAG-Sox9 immobilized on beads was incubated with
HeLa cell nuclear extract and the bound proteins collected and
analyzed. NuPAGE analysis identified a protein that had specif-
ically bound to Sox9 (see the open arrowhead in Figure 1A). The
protein contained in this band was analyzed by matrix assisted
laser desorption ionisation time-of-flight mass spectrometry
(MALDI–TOF MS), and identified as Exp4. To further confirm
the interaction between Sox9 and Exp4 in physiological
conditions, we performed immunoprecipitation experiments for
the proteins endogenously expressed in cultured cells using anti-
Sox9 antibody. We found that Sox9 co-immunoprecipitated with
Exp4 (Figure 1B). These results suggest that endogenous Sox9
binds to Exp4 in the cell.
The HMG box domain of Sox9 is responsible for the
interaction of Sox9 with Exp4
To identify the molecular domains of Sox9 that interact with
Exp4, GST-tagged fragments of Sox9 were prepared (Figure 1C,
D) and subjected to pull-down assays using nuclear extracts from
HeLa cells (see Materials and Methods for details). Western blotting
analysis with anti-Exp4 antibody showed that region #2 (95–186
a.a.), which carries the DNA binding HMG box domain, bound to
Exp4, whereas regions #1 (1–99 a.a.), #3 (173–399 a.a.) and #4
(336–507 a.a.), and GST alone did not (Figure 1D). These results
indicate that the HMG box domain of Sox9 is responsible for the
interaction of Sox9 with Exp4.
Interaction of Exp4 with other members of the Sox family
As a recent report shows that Exp4 interacts with Sox2 and
SRY, both members of the HMG box family of proteins [22], we
examined whether Exp4 interacts with other subgroups of the Sox
Figure 1. Identification of Exp4 as a major interaction partner of Sox9. (A) Silver staining of Sox9 binding proteins separated by NuPAGE.
Nuclear extracts prepared from HeLa cells (HeLa NE) were incubated with (lanes 3, 4) or without FLAG-tagged Sox9 (FLAG-Sox9, lanes 1, 2). After
recovery with anti-FLAG M2 antibody-conjugated agarose, the proteins were subjected to NuPAGE. The closed arrowhead indicates FLAG-Sox9, and
the open arrowhead indicates the protein that was specifically recovered by FLAG-Sox9 (lane 4). (B) Nuclear extracts from U2OS cells were subjected
to immunoprecipitation with anti-Sox9 antibody, and the precipitates were subjected to Western blotting analysis using anti-Exp4 antibody (right
lane). Normal rabbit IgG was used as a control (middle lane). 1% of the nuclear extract was applied as a control (left lane). (C) The schematic depicts
the truncated forms of Sox9 fused with GST (dark gray boxes). The numbers indicate the amino acid residues. The HMG box domain is shown as a
light gray box (103–181 a.a.). (D) The upper panel shows Western blotting analysis of the protein samples co-precipitated with GST-fused truncated
forms of Sox9 using an anti-Exp4 antibody. 5% of the nuclear extract was applied as a control (left lane). Numbers represent the corresponding GST-
fused truncated Sox9 constructs shown in C. The lower panel shows CBB staining of NuPAGE for the GST fusion proteins used in this experiment.
Numbers on the right represent the molecular weights of the marker proteins.
doi:10.1371/journal.pone.0025694.g001
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Sox11 (from group C). To test if they bind to Exp4 in the cell, HA-
tagged Sox9, Sox2, or Sox11 (Figure 2A) was expressed together
with FLAG-Exp4 in HEK293 cells and the cell lysates were
subjected to immunoprecipitation experiments using anti-HA
antibody (Figure 2B). Western blotting analysis of the immuno-
precipitates showed that HA-Sox9 and HA-Sox2, but not HA-
Sox11, co-immunoprecipitated with FLAG-Exp4 (lanes 6–8 in
Figure 2B), indicating that Exp4 binds to limited set of Sox protein
family members.
As our experimental data show that the HMG box domain of
Sox9 is responsible for binding with Exp4 (see Figure 1D), we next
examined whether differences in the ability of the Sox family
proteins to bind Exp4 reflected differences in their HMG box
domains. GST-tagged HMG box fragments of Sox2, Sox9 and
Sox11 were prepared and subjected to GST pull-down assays with
purified recombinant FLAG-Exp4 protein. The Sox2 fragment
(33–123 a.a.) and the Sox9 fragment (95–186 a.a.) directly bound
Exp4, whereas the Sox11 fragment (38–130 a.a.) and GST alone
did not (Figure 2C). These results indicate that the HMG box
domain is primarily responsible for binding of Sox family proteins
to Exp4.
Effect of Exp4 on Sox9-mediated transcription
To elucidate how Exp4 affects the functions of Sox9, we first
examined whether ectopically expressed Exp4 reduced Sox9-
mediated activation of transcription. As the reporter gene, we used
a DNA construct containing three repeats of the Col2a1 enhancer
sequence that binds Sox9 and the thymidine kinase (tk) promoter
fused to the firefly luciferase (Luc) gene (Col2a1x3-tk-Luc). In the
presence of Sox9, transcription of the reporter gene dramatically
increased (compare bars of Sox9 ‘‘0 ng’’ with those of ‘‘50 ng’’ in
Figure 3A). However, the increase in transcriptional activation was
significantly reduced in the presence of Exp4, and this reduction
was dose-dependent (compare the right three bars of Exp4 0, 20,
and 100 ng in Figure 3A). These results suggest that Exp4
effectively suppresses the transcriptional activity of Sox9.
To confirm the suppressive function of Exp4 in physiological
conditions, we performed loss-of-function studies with siRNAs in
U2OS cells, which endogenously express Exp4 and Sox9: our
method of siRNA knockdown for Exp4 or Sox9 successfully
depleted these proteins from the cells (Figure 3B). We first
examined the effect of Exp4 on the transcriptional activity of Sox9
on the Col2a1 gene, which is a well-known direct target gene of
Sox9. As expected, depletion of Sox9 significantly reduced
transcription of this endogenous target gene (Figure 3C). Depletion
of Exp4 enhanced transcription of the Col2a1 gene by 3-fold
(Figure 3C). These results indicate that Exp4 suppresses the
transcriptional activator function of Sox9. Since Exp4 is known to
be involved in both nuclear import [22] and export [20,21], this
raises the possibility that Exp4 affects the transcriptional activity of
Sox9 through re-localization of Sox9. Thus, we examined whether
siRNA knockdown of Exp4 alters the intracellular localization of
Sox9 in U2OS cells. As it has been shown that Exp4 exports eIF-
5A from the nucleus [20], we used eIF-5A as an internal control
for the depletion of Exp4. Treatment with siRNA for Exp4 clearly
induced nuclear localization of eIF-5A (Figure 3D), but had no
effect on Sox9 localization (Figure 3D). These results indicate that
the effects of Exp4 on the transcriptional activity of Sox9 do not
involved changes in Sox9 localization.
Exp4 inhibits Sox9 transcriptional activity through the
HMG box
To test whether the suppression of Sox9 transcriptional activity
depends on the Sox9 HMG box, we made a GAL4-Sox9 fusion
construct in which the HMG box of Sox9 (181–507 a.a.) was
replaced with the GAL4 DNA-binding domain; the GAL4-Sox9
Figure 2. Interaction of Exp4 with Sox family members. (A)
Schematic representation of HA-tagged Sox proteins used in this study.
The numbers indicate the amino acid residues. The HMG box domain is
shown as a light gray box. The percentage of amino acid identity with
the amino acid sequence of the HMG domain of Sox9 is given. (B) The
panels show HA-affinity purification of proteins from extracts of HEK293
cells which were transiently transfected with FLAG-Exp4 and HA-Sox9,
HA-Sox2, or HA-Sox11. Mock refers to the empty control plasmid.
Starting materials (2% input) and bound fractions (IP, immunoprecip-
itation) were analyzed by NuPAGE and Western blotting. HA-tagged
proteins are asterisked in the lower panels. The arrow indicates
nonspecific bands. (C) The GST-fused HMG box domains of each Sox
protein were separated by NuPAGE and stained with CBB (lower panel).
The fusion proteins were incubated with recombinant Exp4 proteins.
Proteins bound to glutathione-Sepharose were analyzed by Western
blotting with anti-Exp4 antibody (upper panel). 20% input represents
the control.
doi:10.1371/journal.pone.0025694.g002
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of Sox9 [16] (Figure 4A). As the reporter gene for GAL4-Sox9, we
used a DNA construct containing 4 repeats of the GAL4 binding
sequence (upstream activating sequence) and the tk promoter
fused to the firefly luciferase gene (UASG64-TK-LUC) [23]. The
wild type Sox9 construct was co-transfected into HEK293 cells
with Col2a1x3-tk-Luc, or the GAL4-Sox9 construct was co-
transfected into HEK293 cells with UASG64-TK-LUC. In the
presence of full-length wild type Sox9, transcription of the
Col2a1x3-tk-Luc reporter gene increased and the activation was
significantly reduced in the presence of Exp4 (Figure 3A, 4B). In
contrast, while the transcription of the UASG64-TK-LUC
Figure 3. Effects of Exp4 on the localization of Sox9 and Sox9-mediated transcription. (A) The effect of Exp4 on Sox9-mediated
transcription. HEK293 cells were transiently transfected with the luciferase reporter gene (Col2a1x3-tk-Luc) and the indicated amounts (ng) of Sox9
and Exp4. Values are the mean 6 SD of at least three experiments. (B) The knockdown efficiency of siRNA for Sox9 and Exp4. U2OS cells were treated
with control siRNA, siRNA for Sox9, or siRNA for Exp4. The efficacy of siRNA was monitored by detecting protein levels by Western blotting. (C) The
effect of Exp4 depletion on Sox9 target gene expression. U2OS cells were treated with the indicated siRNAs and the mRNA for Col2a1 was examined
by qRT-PCR. The relative amount of Col2a1 mRNA is shown: the amount of Col2a1 mRNA from the control siRNA cells is set at 100. Values are the
mean 6 SD of at least three experiments. (D) The effect of Exp4 depletion on the localization of endogenous Sox9. U2OS cells were treated with
siRNA for Exp4 or control siRNA. Cells were incubated with anti-Sox9 antibody and anti-eIF-5A, and visualized using an Alexa488-conjugated
secondary antibody and a Cy3-conjugated secondary antibody. Nuclei were visualized by staining with DAPI. The same cells are shown for each of the
siRNAs.
doi:10.1371/journal.pone.0025694.g003
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Sox9, the activation was not reduced in the presence of Exp4
(Figure 4C). These data indicate that the HMG box of Sox9 is
essential for Exp4 dependent suppression, and suggest that Exp4
has a direct role in suppression of Sox9 through the HMG box.
This binding scheme distinguishes Exp4 from the known co-
regulators which bind to the TA domain of Sox9.
Exp4 inhibits the DNA-binding activity of Sox9
As Exp4 suppresses Sox9-mediated transcription through its
HMG box, this raises the possibility that Exp4 might inhibit DNA
binding of Sox9 to its target DNA sequence. To examine this
possibility, we treated U2OS cells with siRNA for Exp4 and
performed chromatin immunoprecipitation (ChIP) assays with
anti-Sox9 antibody or control antibody. The recovered chromatin
was amplified using primers specific for Col2a1. In Exp4
knockdown cells, recruitment of endogenous Sox9 to the Col2a1
gene was 1.9-fold higher than in control cells (Figure 5A). These
results suggest that Exp4 suppresses the DNA-binding activity of
Sox9 in vivo.
To further confirm that Exp4 inhibits the DNA binding activity
of Sox9, we performed a DNA pull-down assay using purified
recombinant Sox9 and Exp4 proteins in vitro. A biotinylated 18 bp
sequence of the Col2a1 intronic enhancer element was used as
described in Materials and Methods (Figure 5B). Sox9 proteins bound
to the intronic enhancer sequence (lane 2 in Figure 5C), and Exp4
inhibited the binding of Sox9 to the sequence in a dose-dependent
manner (lanes 3–6 in Figure 5C). These results indicate that Exp4
suppresses the transcriptional activity of Sox9 by inhibiting its
DNA binding activity.
Discussion
In the present study, we purified proteins which stably interact
with Sox9, and identified Exp4 as a major interacting partner
protein of Sox9. Our results show that Exp4 controls Sox9-
mediated transcriptional activity by modulating the DNA binding
ability, but not the intracellular localization, of Sox9.
Roles of Exp4 in suppression of Sox9-mediated
transcriptional activation
Exp4 is a member of the exportin family. Exportins belong to
the importin b superfamily of transport proteins. Exportins are
known to export cargo (RNAs and/or proteins) from the nucleus
to the cytoplasm by binding cargo in the presence of RanGTP:
Exp4 exports eIF-5A and Smad3 to the cytoplasm in the presence
of RanGTP [20,21]. However, Exp4 seems to have different
modes of transport. It has been reported that Exp4 can also import
Sox2 and SRY proteins into the nucleus in a Ran-independent
manner [22]. Interestingly, Go ¨rlich and his colleagues have
reported that thymidylate synthase preferentially binds Exp4 in
the absence of Ran and its binding does not affect localization of
the protein [20]. Likewise, our results showed that Exp4 directly
bound Sox9 in vitro in the absence of RanGTP, and that Exp4 does
not affect the cellular localization of Sox9.
The depletion of Exp4 clearly increased the binding of Sox9 to
its target gene and increased the expression of the gene without
altering the cellular localization of Sox9. These findings raise the
possibility that Exp4 has an additional function when it binds to
Sox9 in the nucleus. Previous reports suggest that the importin b
Figure 4. Replacing the HMG box of Sox9 abolished the
inhibitory effect of Exp4 on Sox9 transcription. (A) Schematic
representation of GAL4-fused Sox proteins (GAL4-Sox9) used in this
study. The TA domain is shown as a light gray box (406–507 a.a.). (B)
The effect of Exp4 on Sox9-mediated transcription of the Col2a1
reporter gene (Col2a1x3-tk-Luc). HEK293 cells were transiently trans-
fected with the reporter gene and the indicated amounts (ng) of Sox9
or Exp4. The relative fold changes in the luciferase activities are shown:
luciferase activity in the presence of 50 ng of Sox9 and the absence of
Exp4 is set at 100. Values are the mean 6 SD of at least three
experiments. (C) The effect of Exp4 on GAL4-Sox9 mediated transcrip-
tion of the GAL4 reporter gene (UASGx4-TK-LUC). HEK293 cells were
transiently transfected with the reporter gene and the indicated
amounts (ng) of GAL4-Sox9 or Exp4. The relative fold changes in the
luciferase activities are shown: luciferase activity in the presence of
50 ng of GAL4-Sox9 and the absence of Exp4 is set at 100. Values are
the mean 6 SD of at least three experiments.
doi:10.1371/journal.pone.0025694.g004
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highly charged basic proteins such as ribosomal proteins and
histones prior to binding to nucleic acids [24,25]. This suggests
that importin family proteins modulate DNA binding activity by
neutralizing highly charged DNA binding domains. Since the
HMG box of Sox9 is also a highly charged DNA binding domain
containing a number of Lysine and Arginine residues, Exp4 may
act as a ‘‘neutralization factor’’ or ‘‘chaperone’’ for the highly
charged HMG box of Sox9 and repress the function of Sox9 by
suppressing its ability to bind to its target DNA.
There was, however, another possible means by which Exp4
could suppress Sox9 transcription: by exporting cofactors required
for Sox9-mediated transcription out of the nucleus. To test this
possibility, we replaced the HMG box of Sox9 with the DNA
binding domain of GAL4, leaving the C-terminal intact. It is
known that the C-terminal of Sox9 bears the transactivating
function [16,17]. Mutations in this domain cause the Sox9-
dependent disease ‘‘campomelic dysplasia’’ with skeletal dysmor-
phology/sex reversal, and this disease is due to loss of transcription
activation function [26]. Therefore, if Exp4 removed essential
cofactors, such as Smad3, by exporting them out of the nucleus,
GAL4-Sox9 would loose transcription activation function in the
presence of Exp4. This was not the case (Figure 4C); Exp4 did not
affect transcription activity in the absence of the N-terminal HMG
domain. This finding supports the idea that Exp4 directly regulates
Sox9 function through the HMG box and not through the export
of Sox9 cofactors.
A functional link between DNA-binding and NLS/NES
Previous studies have reported that many types of transcription
factors possess an NLS or NES near their DNA binding domains.
Examples include helix–loop–helix [27], Zn finger [28], Forkhead
[29] and HMG box [2] transcription factors. Interestingly, Cokol
et al. found by in silico analysis that about 90% of the DNA binding
regions overlap a NLS region [30]. This supports our hypothesis
that factors which bind a NLS and/or NES can regulate
transcriptional activity by modulating binding to DNA.
This hypothesis is supported by three examples. The first
example is interaction between a 14-3-3 protein complex, which
works as a molecular scaffold, and the Forkhead DNA binding
domain of FOXO4. FOXO4 has three 14-3-3 binding sites, and
the Forkhead DNA binding domain lies between the 59 site and
the middle site. Moreover, the middle 14-3-3 binding site
overlaps the FOXO4 NLS. Binding of the 14-3-3 complex to
the 59 and middle sites of FOXO4, completely inhibits the
binding of FOXO4 to its target DNA and causes rapid export of
FOXO4 from the nucleus [31]. The second example is the
interaction of importins with the yeast transcription factor GAL4.
Importin b inhibits GAL4-DNA binding by competing with DNA
for binding to GAL4. On the other hand, the GAL4 which does
bind to DNA is recognized by importin a, and importin a
stabilizes GAL4-DNA binding [28]. The third example is the
result presented in this report: Exp4 binds to Sox9 and inhibits
Sox9-DNA binding.
Interestingly, our data show that Exp4 prevents Sox9 from
binding to the Col2a1 gene without affecting the localization of
Sox9. This prompts us to speculate that transcriptional factors
such as Sox9 may have two forms in the nucleus, a chromatin-
bound form and an unbound form, and that these two forms of
Sox9 exist in an Exp4-mediated equilibrium. Such dynamic
exchange of transcriptional factors must be precisely and
temporally regulated by co-regulators. Thus, we propose that
Exp4 is a transcriptional co-regulator which controls the initiation
rate of Sox9-mediated transcription by preventing DNA binding
by Sox9.
Materials and Methods
Purification of proteins which interact with Sox9
Recombinant FLAG-tagged Sox9 protein was expressed in a
baculovirus expression system in Sf21 cells as previously reported
[32]. Briefly, the cells were lysed in B400 buffer (20 mM Tris-HCl
Figure 5. Effect of Exp4 on Sox9 binding to its target gene. (A)
The effect of Exp4 depletion on the recruitment of Sox9 to its
endogenous target gene. U2OS cells were treated with control siRNA
(open bar) or siRNA for Exp4 (solid bar). After a 48 h incubation, fixed
chromatin was prepared from both groups of treated cells and
subjected to immunoprecipitation with anti-Sox9 antibody. The Col2a1
enhancer regions recovered in the two precipitated fractions were
quantified by PCR. As a control, GAPDH genes recovered in the two
precipitated fractions were quantified. The relative amount of enhancer
DNA is shown: the amount of Col2a1 enhancer DNA obtained from the
control siRNA cells is set at 100. (B) The DNA sequence of the probe
used for DNA pull-down contains a biotinylated 18 base-pair Sox9
binding sequence of the Col2a1 enhancer region. (C) DNA pull-down
assay with the indicated amounts (ng) of His-Sox9 and FLAG-Exp4. His-
Sox9 and FLAG-Exp4 were incubated with a 59 biotinylated double-
stranded DNA probe. The complex was pulled down with streptavidin-
agarose and the streptavidin-agarose bead bound fraction and flow-
through fractions (FT) were analyzed by Western blotting.
doi:10.1371/journal.pone.0025694.g005
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Tween20 and complete protease inhibitor cocktail (Roche,
Mannheim, Germany)), and the FLAG-tagged Sox9 was collected
with anti-FLAG M2 agarose (Sigma, St Louis, MO, USA). The
agarose beads were washed with B100 buffer (20 mM Tris-HCl
(pH 8.0), 100 mM KCl, 10% glycerol, 5 mM MgCl2, 0.1%
Tween20 and complete protease inhibitor cocktail), and were
incubated with nuclear extract prepared from HeLa S3 cells [33]
for 3 hr at 4uC. The beads were then washed five times with B150
buffer (20 mM Tris-HCl (pH 8.0), 150 mM KCl, 10% glycerol,
5 mM MgCl2, 0.1% Tween20 and complete protease inhibitor
cocktail), and the proteins bound to the beads were eluted with
0.1 M glycine-HCl (pH 2.5) and separated on 4% to 12%
polyacrylamide gels (NuPAGE, Invitrogen, Carlsbad, CA, USA).
The proteins recovered from the gel were analyzed by mass
spectrometry.
Plasmids
The full-length cDNA for human Exp4 was obtained as
follows. The 59 region of Exp4 in the Celera 59 EST Clone
19600417490688 (Invitrogen) was removed by digestion with
Asp718/EcoRI and then inserted into the corresponding sites in
pBluescript SK+ (Stratagene, La Jolla, CA, USA). The 39 region
of Exp4 in IMAGE Clone 1625054 (GenBank accession
no. AA993090, Invitrogen) was removed by digestion with
EcoRI/NotI and inserted into the corresponding sites of the
pBluescript SK+ plasmid containing the 59 region of Exp4.
Finally, the middle region of Exp4 was removed from IMAGE
Clone 614088 (GenBank accession no. BC050680, Invitrogen) by
digestion with EcoRI and inserted into the relevant sites of the
pBluescript SK+ plasmid containing the 59 and 39 regions of
Exp4. The resulting full-length Exp4 cDNA was subcloned into
pFASTBAC for protein production in a baculovirus system and
into pCAGGS [34] for expression in mammalian cells. Mouse
Sox2 (Sox2) and mouse Sox11 (Sox11) were constructed with
cDNAs that had been generously provided by Dr. Hisato
Kondoh (Osaka University, Osaka, Japan), and N-terminal HA-
tags fused in-frame with Sox2, Sox11, and Sox9 [35] were
inserted into the pcDNA3 vector (Invitrogen). The luciferase
reporter plasmid, Col2a1x3-tk-Luc, was constructed so as to
contain three copies of the Col2a1 enhancer element directly
upstream of the tk basal promoter. pCMX-GAL4 [36] encodes
the GAL4 DNA binding domain (1–147 a.a.). pCMX-GAL4-
Sox9 was constructed by inserting a PCR-amplified DNA
fragment encoding amino acids 181 to 507 of mouse Sox9 into
pCMX-GAL4 cleaved with Asp718 and BamHI. The luciferase
reporter plasmid, UASG64-TK-LUC [23], was used with GAL4-
Sox9. The sequences of all of the plasmids used in this study were
checked using an ABI prism310 DNA sequencer (Applied
Biosystems, CA, USA).
Preparation of Anti-Exp4 Antibody
His-tagged Exp4 (His-Exp4, 931–1125 a.a.) corresponding to
the C-terminal region of human Exp4 was cloned into pET28a
(Stratagene) and expressed in Escherichia coli BL21 (DE3). The E.
coli were lysed in G buffer containing 6 M guanidine-HCl, 20 mM
Tris-HCl (pH 8.0), 500 mM KCl, 10% glycerol, 5 mM MgCl2,
0.1% Tween 20, and 20 mM Imidazol. The lysates were mixed
with Ni
2+ resin (Sigma) at room temperature for 1 hr. Then, His-
Exp4 was eluted with G buffer containing 200 mM Imidazole.
The protein solution was subjected to dialysis with buffer
containing 50 mM Tris-HCl (pH 8.0), and 150 mM NaCl to
remove guanidine. Polyclonal Exp4 antibodies were produced by
Sigma-Aldrich Life Science Japan using His-Exp4 protein as an
antigen, produced as described above. Anti-Exp4 antibody was
purified by affinity to an antigen-conjugated column and was used
for immunoblotting to test its specificity.
Cell culture, transient transfection, and reporter assay
HeLa S3 cells (ATCC CCL-2.2; American Type Culture
Collection), HEK293 cells (ATCC-CRL-1573) and U2OS cells
(ATCC HTB-96) were grown in Dulbecco’s modified Eagle’s
medium (DMEM) (Sigma) supplemented with 10% fetal bovine
serum (JRH Sciences, Lenexa, KS) and 16penicillin-streptomycin-
glutamine (Invitrogen) at 5% CO2 and 37uC. For reporter assays,
5610
4 HEK293 cells were seeded into 24-well plates and
incubated for 24 hr before transfection with Lipofectamine 2000
reagent (Invitrogen) according to the manufacturer’s protocol.
Cells were co-transfected with three plasmids: the Sox9/GAL4-
Sox9 expression plasmid, the Exp4 expression plasmid, and
200 ng of luciferase reporter plasmid. The total amounts of the
transfected plasmids were adjusted to 600 ng with an empty vector
plasmid. 50 ng of pRL-SV40 (Promega, Madison, WI, USA) was
used as an internal control to normalize the transfection
efficiencies. The cells were harvested 36 hr after transfection and
the cell lysates were subjected to luciferase assay using the Dual-
Luciferase Assay System (Promega). All transfection experiments
were performed in triplicate.
Immunoprecipitation and Western blotting
To detect the interaction of endogenous Sox9 and Exp4 in cells,
nuclear extracts from U2OS cells were incubated with anti-Sox9
antibody kindly provided by Prof. K. Morohashi (Kyushu
University, Fukuoka, Japan) at 4uC for 1 hr. Normal rabbit
IgG was used as a control. Immune complexes with anti-Sox9
antibodies were recovered with protein A-Sepharose (GE
Healthcare UK Ltd., UK) and subjected to Western blotting
analysis using anti-Exp4 antibody. To detect the interaction of
Exp4 and Sox family members in cultured cells, the HA-tagged
expression plasmids for the Sox family members were co-
transfected into HEK293 cells for 36 hr with the Exp4 expression
plasmid. The cells were lysed and incubated with anti-HA
(12CA5) antibody (Roche) conjugated protein A-Sepharose. The
immunoprecipitates were separated on NuPAGE and subjected to
Western blotting analysis using anti-Exp4 antibody and anti-HA
(12CA5) antibody.
GST pull-down assays
Various regions of Sox9 were amplified by PCR, inserted into
pGEX-6P-1 (GE Healthcare UK L t d . ) ,a n de x p r e s s e da sG S T -
fused proteins in E.coli. The E.coli were sonicated in B400 buffer.
After centrifugation at 70,0006g for 20 min, the supernatants
were incubated at 4uC for 3 hr with glutathione-Sepharose (GE
Healthcare UK Ltd.). After the incubation, the glutathione-
Sepharose was washed three times with B400 buffer, washed
two times with B100 buffer, and then incubated with nuclear
extracts from HeLa cells at 4uC for 2 hr. The proteins bound to
the Sepharose were eluted by lithium dodecyl sulfate (LDS)
sample buffer (Invitrogen) and subjected to Western blotting
analysis using anti-Exp4 antibody. The GST-fused proteins
including the HMG box regions of Sox2, Sox9 and Sox11 were
expressed in E.coli and prepared as described above. Each GST-
fused protein solution was incubated with purified recombinant
FLAG-Exp4 protein and glutathione Sepharose at 4uCf o r2h r .
The proteins bound to the Sepharose were eluted by LDS
sample buffer and subjected to Western blotting analysis with
anti-Exp4 antibody.
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2610
5 U2OS cells were seeded into 6-well plates. After 24 hr,
the cells were transfected with 50 nM siRNA duplexes for Exp4 or
for Sox9 (Sigma) using 5 ml Lipofectamine RNAiMax reagent
(Invitrogen). A control siRNA (Mission siRNA Universal Negative
Control, Sigma) was used as a negative control. After a 6 hr
incubation with the transfection reagents, the cells were cultured in
fresh culture medium for 30 hr. Total RNA was prepared from
the cells using a Fastpure RNA kit (Takara bio Inc., Japan), and
was reverse-transcribed using a high-capacity RNA-to-cDNA
Master Mix (Applied Biosystems). qRT-PCR was performed with
an ABI PRISM 7700 Sequence Detection System (Applied
Biosystems). Power SYBR Green (Applied Biosystems) was used
as a fluorescent dye. Specific primers for the Col2a1 and GAPDH
genes were as follows (59 to 39): Col2a1, forward: CCGGGCA-
GAGGGCAATAGCAGGTT; reverse: CATTGATGGGGAGG
CGTGAG; GAPDH, forward: CGGAGTCAACGGATTTGGT
CGTAT; reverse: AGCCTTCTCCATGGTGGTGAAGAC.
Immunohistochemistry of siRNA transfected cells
For microscopic observation of siRNA transfected cells, 1610
5
U2OS cells were seeded into 35 mm glass bottom culture plates,
and 12 hr later U2OS cells were transfected with 50 nM siRNA for
Exp4 (Sigma) using Lipofectamine RNAiMax reagent according to
the manufacturer’s protocol. The control siRNA (Mission siRNA
Universal Negative Control; Sigma) was used as a control. After a
6 hr incubation with the transfection reagents, the cells were
cultured in fresh medium for 42 hr. The cells were fixed with 4%
formaldehyde in phosphate-buffered saline (PBS) for 30 min at
room temperature and washed three times with PBS containing
0.1% TritonX-100 (PBSTX). The cells were then incubated with
Blocking One (Nakarai tesque Inc., Japan) for 30 min. The cells
were incubated with anti-eIF-5A antibody (Cell Applications Inc.,
CA,USA,1:200dilution)andanti-Sox9antibody(Invitrogen,1:500
dilution) for 16 hr at 4uC, washed three times with PBSTX, and
then, incubated with Alexa488-conjugated anti-rabbit IgG (Invitro-
gen, 1:2000 dilution) and Cy3-conjugated anti-mouse IgG (GE,
1:2000dilution) atroom temperaturefor2 hr.Finally,thecellswere
washed three times with PBSTX, incubated with 50 ng/ml 49,6-
diamidino-2-phenylindole (DAPI) for 10 min, and mounted with
60% glycerol-PBS for fluorescence microscopy. Cells were analyzed
andphotographedwith aDeltaVisionRTsystem(AppliedPrecision
Inc., WA, USA).
ChIP Assays
After cross-linking U2OS cells with 0.75% formaldehyde for
10 min at room temperature, cells were rinsed twice with cold
PBS, harvested in lysis buffer containing 50 mM Tris-HCl
(pH 8.0), 10 mM EDTA and 1% SDS, and incubated for 5 min
at room temperature. Their chromatin was sonicated to generate
DNA fragments of 500–1000 base pairs. The chromatin solution
was diluted by 0.1% SDS with dilution buffer containing 20 mM
Tris-HCl (pH 8.0), 2 mM EDTA, 150 mM NaCl and 1%
TritonX-100, and incubated with normal rabbit IgG or anti-
Sox9 antibody, and Dynabeads Protein A (Invitrogen) overnight at
4uC. Next, Dynabeads Protein A adsorbed to the immunocom-
plexes were collected and washed three times with 50 mM Tris-
HCl (pH 8.0), 5 mM EDTA, 150 mM NaCl, 0.5% Nonidet P-40,
0.1% SDS and Protease inhibitor Cocktail, and finally the
chromatin fragments were eluted from the beads with 1% SDS
in 0.1 M NaHCO3. After the cross-linking was reversed by
heating overnight at 65uC, DNA fragments were recovered using a
QIAquick Gel Extraction Kit (Qiagen, Japan). The purified DNA
fragments were used for qRT-PCR with an ABI PRISM 7700
Sequence Detection System. Power SYBR Green was used as a
fluorescent dye. Specific primers for the Col2a1 and GAPDH genes
were as follows (59 to 39): Col2a1, forward: ACCTGTGAA
TCGGGCTCTGT; reverse: CCCACTGGACCTCGTCTCTC;
GAPDH, forward: GGTTTACATGTTCCAATATGATTCCA;
reverse: AAGATGGTGATGGGATTTCCAT.
Protein-DNA binding analysis
His-tagged Sox9 protein was expressed in a baculovirus
expression system as described previously [35]. The cells were
lysed in B400 buffer. The His-tagged proteins were recovered with
aN i
2+ Sepharose column using a liquid chromatography system,
the A ¨KTA explorer10S (GE Healthcare UK Ltd). An equal
quantity of biotinylated sense (59-bio-aaagccccattcatgaga-39) and
un-biotinylated anti-sense (59-tctcatgaatggggcttt-39) DNA were
mixed and incubated at 95uC for 5 min. This was then cooled
down to room temperature to generate double stranded DNA.
50 ml of streptavidin-agarose (Upstate Biotechnology Inc., NY,
USA) was mixed with 100 pmol of double stranded DNA,
incubated at 4uC for 30 min, and then, washed with B100 buffer.
Next, the agarose beads were incubated with His-Sox9 (0 or 50 ng)
and FLAG-Exp4 (0–200 ng) in B100 buffer at 4uC for 3 hr, and
washed three times with B100 buffer. Finally, the proteins bound
to the DNA were eluted in LDS sample buffer and analyzed by
Western blotting with an anti-Exp4 or anti-Sox9 antibody.
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